European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 7, Status: Authorised

Submitted by Anonymous (not verified) on 8 October 2026 - 16:25

Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 7, Status: Authorised

Clinical Trials Information System (CTIS): Walk-in clinic October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 7 October 2026, 16:00 (CEST) to 7 October 2026, 17:00 (CEST)

Submitted by Anonymous (not verified) on 8 October 2026 - 14:23

Clinical Trials Information System (CTIS): Walk-in clinic October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 7 October 2026, 16:00 (CEST) to 7 October 2026, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 19, Status: Authorised

Submitted by Anonymous (not verified) on 8 October 2026 - 14:22

Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 22, Status: Authorised

Submitted by Anonymous (not verified) on 8 October 2026 - 12:48

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 22, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More